RecruitingNot Applicable

Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss

Israel60 participantsStarted 2021-02-16

Plain-language summary

Assessing the efficiency of Prophylactic use of local tranexamic acid during vaginal hysterectomy to reduce blood loss during operation

Who can participate

Age range20 Years – 90 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 20-90 years old female patients going through vaginal hysterctomy Exclusion Criteria: * massive bleeding during operation due to major vessles injury * known coagulopathies * sensitivity to tranexamic acid * medical need in tranexamic acid administration during operation due to bleeding

What they're measuring

Blood loss during operation - measure in ml

Timeframe: End of surgery

Trial details

NCT IDNCT04760301

SponsorMeir Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-07

Contact for this trial

Yair Daykan, M.D

0542198231 yair.dykan@gmail.com

View on ClinicalTrials.gov More Blood Loss trials